Preferred stimulant safer supply and associations with methamphetamine preference among people who use stimulants in British Columbia: Findings from a 2021 cross-sectional survey.
Max Ferguson, Kali-Olt Sedgemore, Marnie Scow, Paul Choisil, Beth Haywood, Jessica Xavier, Alexis Crabtree, Blake Stitilis, Lisa Liu, Jane A Buxton
Author Information
Max Ferguson: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Kali-Olt Sedgemore: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Marnie Scow: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Paul Choisil: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Beth Haywood: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Jessica Xavier: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Alexis Crabtree: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Blake Stitilis: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Lisa Liu: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Jane A Buxton: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: Jane.Buxton@bccdc.ca.
BACKGROUND: As safer supply programs expand in Canada, stimulant safer supply is often overlooked despite the harms and criminalization faced by people who use stimulants. METHODS: The 2021 Harm Reduction Client Survey was administered at 17 harm reduction sites around British Columbia, Canada. The survey included a question about what specific substance participants would want to receive as stimulant safer supply. We investigated preference of stimulant safer substance by looking at frequency of stated preference and by using multivariable logistic regression to understand factors associated with the most frequently chosen substance. RESULTS: Of 330 participants who reported a stimulant safer supply preference, 58.5% (n = 193) chose crystal methamphetamine, 13% (n = 43) crack cocaine and 12.4% (n = 41) cocaine powder. The options that were available by prescription at the time of data collection were chosen by under 11% of participants (dextroamphetamine n = 21, methylphenidate n = 15). A preference for crystal methamphetamine was associated with being 29 and under compared to 50 and over (AOR: 3.96, 95% CI: 1.42-11.07, p-value: 0.01); self-identifying as a cis man versus a cis woman (AOR: 1.75, 95% CI: 1.03-2.97, p-value: 0.04); and using drugs every day (AOR: 15.43, 95% CI: 3.38-70.51, p-value: < 0.01) or a few times a week (AOR: 8.90, 95% CI: 1.78-44.44, p-value: 0.01) compared to a few times a month. CONCLUSIONS: Preference of stimulant safer supply is associated with age, gender, and substance use characteristics. Safer supply programs that offer limited substances risk being poorly accessed, resulting in a continued reliance on an unregulated supply. Moreover, programs that do not offer a range of substances can contribute to health inequities.
